We hypothesized that the vaccination of the mice with D2SC/1–mp53 cells caused a selective pressure on the tumor and that tumor cells that grew out after a latency period might have acquired a p53 negative phenotype preventing immunological recognition. The gene discussed is TP53; the disease is neoplasm.